Who invested in ImmuneBridge

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$13Mraised across 2 rounds since 2025, from 2 sources

$5.6MVenture$7.7MSeed

Latest round: Seed, $7.7MMar 2026
Step-upi: 1.4×
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026

$5.6MVenture$7.7MSeed

First round: Venture, $5.6M
Biggest round: $7.7M
Between rounds: 11 months

The rounds

Mar 2026
Seed$7.7M1 new4 returning
Source recorded
Apr 2025
Venture$5.6M5 new
Source recordedSEC filing: $5.6M sold, first sale Mar 2025

Founders and team

From ImmuneBridge's own website: 5 on the team.

James LiuChief Technology Officer
Alicia RomeroOperations Manager
Dylan MorrisBoard Member
Kimberly ZaiMachine Learning and Data Engineer
S. Alexander JacobsonBoard Member

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2025Seed2026

Everyone who backed them

GaingelsPrivate equity2rounds

Insight PartnersVC firm2rounds

Pioneer FundPrivate equity2rounds

Quiet CapitalVC firm2rounds

NFXVC firm1round

One Way VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists ImmuneBridge as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.